Ticker: TARA

Protara Therapeutics, Inc. (NASDAQ: TARA) Quick read - what's happening inside: The company is ramping clinical activity across two lead programs (TARA‑002 in NMIBC and LMs; IV Choline Chloride for parenteral support), increasing R&D spend and advancing THRIVE‑3 and ADVANCED‑2 milestones. Managem...